chrX-154024879-G-GAT
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_001110792.2(MECP2):c.*5486_*5487dupAT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00511 in 111,652 control chromosomes in the GnomAD database, including 4 homozygotes. There are 158 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0051 ( 4 hom., 158 hem., cov: 23)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
MECP2
NM_001110792.2 3_prime_UTR
NM_001110792.2 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.04
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant X-154024879-G-GAT is Benign according to our data. Variant chrX-154024879-G-GAT is described in ClinVar as [Benign]. Clinvar id is 143277.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00511 (571/111652) while in subpopulation NFE AF= 0.00761 (404/53094). AF 95% confidence interval is 0.007. There are 4 homozygotes in gnomad4. There are 158 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MECP2 | NM_001110792.2 | c.*5486_*5487dupAT | 3_prime_UTR_variant | 3/3 | ENST00000453960.7 | NP_001104262.1 | ||
MECP2 | NM_004992.4 | c.*5486_*5487dupAT | 3_prime_UTR_variant | 4/4 | ENST00000303391.11 | NP_004983.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MECP2 | ENST00000453960 | c.*5486_*5487dupAT | 3_prime_UTR_variant | 3/3 | 1 | NM_001110792.2 | ENSP00000395535.2 | |||
MECP2 | ENST00000303391 | c.*5486_*5487dupAT | 3_prime_UTR_variant | 4/4 | 1 | NM_004992.4 | ENSP00000301948.6 |
Frequencies
GnomAD3 genomes AF: 0.00511 AC: 570AN: 111603Hom.: 3 Cov.: 23 AF XY: 0.00467 AC XY: 158AN XY: 33813
GnomAD3 genomes
AF:
AC:
570
AN:
111603
Hom.:
Cov.:
23
AF XY:
AC XY:
158
AN XY:
33813
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 295Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 123
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
295
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
123
Gnomad4 FIN exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00511 AC: 571AN: 111652Hom.: 4 Cov.: 23 AF XY: 0.00466 AC XY: 158AN XY: 33872
GnomAD4 genome
AF:
AC:
571
AN:
111652
Hom.:
Cov.:
23
AF XY:
AC XY:
158
AN XY:
33872
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Rett syndrome Benign:1
Benign, criteria provided, single submitter | curation | Centre for Population Genomics, CPG | Oct 11, 2023 | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 2.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 2.0 (BA1). - |
not specified Benign:1
Benign, no assertion criteria provided | curation | RettBASE | Mar 10, 2010 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at